JCO at ASCO 2026: Individual Patient Pooled Analysis of Low-Dose Tamoxifen in DCIS
About this episode
Dr. Yuvanesh Vedaraju and Dr. Kathy Miller discuss the findings of a pooled analysis on low-dose tamoxifen in non-invasive breast neoplasia presented at ASCO 2026.
JCO Editorial Fellow Dr. Yuvanesh Vedaraju and JCO Associate Editor Dr. Kathy Miller discuss the ASCO 2026 Simultaneous Publication paper " Low-Dose Tamoxifen in Non-Invasive Breast Neoplasia: Long-Term Results from an Individual Participant Data Pooled Analysis ." LINK TO FULL TRANSCRIPT
More episodes of Journal of Clinical Oncology (JCO) Podcast
- Effectiveness of a Virtual Tobacco Treatment for Cancer Patients
- Phase 2 Study of Multi-Cancer Detection from Breath Samples
- JCO at ASCO 2026: Individualized Neoantigen Therapy Plus Pembrolizumab in Melanoma
- JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
- JCO at ASCO 2026: Neoadjuvant Sacituzumab in MIBC
- JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC
Explore listener stats, chart rankings, contacts and more on the Journal of Clinical Oncology (JCO) Podcast podcast page.